Active, not recruitingNot applicableNCT06176859
Delivery Optimization for Pre-Exposure Prophylaxis (DO PrEP) Study
Studying Lethal ataxia with deafness and optic atrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Massachusetts General Hospital
- Principal Investigator
- Zaynab Essack, PhDHuman Sciences Research Council of South Africa
- Intervention
- HIV PrEP Delivery(other)
- Enrollment
- 2500 enrolled
- Eligibility
- 16-30 years · All sexes
- Timeline
- 2023 – 2026
Study locations (1)
- Human Sciences Research Council, Durban, KwaZulu-Natal, South Africa
Collaborators
Bill and Melinda Gates Foundation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06176859 on ClinicalTrials.govOther trials for Lethal ataxia with deafness and optic atrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT06374758Accelerated ART Initiation for PWHIV Who Are Out of CareUniversity of Missouri-Columbia
- RECRUITINGNANCT05912270Orchestra in Class, a Novel Booster for Executive Functions and Brain Development in Young Primary School ChildrenSchool of Health Sciences Geneva
See all trials for Lethal ataxia with deafness and optic atrophy →